Atavistik Bio
Truc Pham's work experience starts with a role as a Research Assistant at the University of New Haven in 2012. In this position, Truc characterized biofilm formation in the Lyme disease agent, B. burgdorferi, and developed cell-based assays to study the viability and morphological changes of the biofilm in response to antibiotic treatments.
Following this, Truc worked as a Graduate Research Assistant and Postdoctoral Scientist at Texas A&M University from 2013 to 2019.
In 2019, Truc joined Tango Therapeutics as a Sr. Scientist, where they worked until September 2021.
Lastly, Truc is currently employed as a Senior Scientist at Atavistik Bio since June 2022.
Truc Pham completed a Bachelor's degree in Chemistry and Biological Chemistry with a focus on Medicinal and Pharmaceutical Chemistry at Nanyang Technological University Singapore from 2007 to 2011. Following this, Truc pursued a Master's degree in Cell/Cellular and Molecular Biology at the University of New Haven from 2011 to 2013. Finally, Truc completed a Doctor of Philosophy (PhD) in Biochemistry, Biophysics, and Molecular Biology at Texas A&M University from 2013 to 2018.
Atavistik Bio
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms.